These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28770950)

  • 1. Prevention of neural tube defects and maternal gestational diabetes through the inositol supplementation: preliminary results.
    Dell'Edera D; Sarlo F; Allegretti A; Epifania AA; Simone F; Lupo MG; Benedetto M; D'Apice MR; Capalbo A
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3305-3311. PubMed ID: 28770950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: study protocol for a randomized controlled trial.
    Asimakopoulos G; Pergialiotis V; Anastasiou E; Antsaklis P; Theodora M; Vogiatzi E; Kallergi A; Sindos M; Loutradis D; Daskalakis G
    Trials; 2020 Jul; 21(1):633. PubMed ID: 32646482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial.
    Celentano C; Matarrelli B; Pavone G; Vitacolonna E; Mattei PA; Berghella V; Liberati M
    J Matern Fetal Neonatal Med; 2020 Mar; 33(5):743-751. PubMed ID: 30558466
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of D-
    Dell'Edera D; Sarlo F; Allegretti A; Simone F; Lupo MG; Epifania AA
    Biomed Rep; 2017 Aug; 7(2):169-172. PubMed ID: 28804631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the use of inositols in preventing gestational diabetes mellitus (GDM) and neural tube defects (NTDs).
    Facchinetti F; Cavalli P; Copp AJ; D'Anna R; Kandaraki E; Greene NDE; Unfer V;
    Expert Opin Drug Metab Toxicol; 2020 Dec; 16(12):1187-1198. PubMed ID: 32966143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial.
    Farren M; Daly N; McKeating A; Kinsley B; Turner MJ; Daly S
    Diabetes Care; 2017 Jun; 40(6):759-763. PubMed ID: 28325784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial.
    Fraticelli F; Celentano C; Zecca IA; Di Vieste G; Pintaudi B; Liberati M; Franzago M; Di Nicola M; Vitacolonna E
    Acta Diabetol; 2018 Aug; 55(8):805-812. PubMed ID: 29774465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial.
    Matarrelli B; Vitacolonna E; D'Angelo M; Pavone G; Mattei PA; Liberati M; Celentano C
    J Matern Fetal Neonatal Med; 2013 Jul; 26(10):967-72. PubMed ID: 23327487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive and Therapeutic Role of Dietary Inositol Supplementation in Periconceptional Period and During Pregnancy: A Summary of Evidences and Future Applications.
    Noventa M; Vitagliano A; Quaranta M; Borgato S; Abdulrahim B; Gizzo S
    Reprod Sci; 2016 Mar; 23(3):278-88. PubMed ID: 26175275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.
    D'Anna R; Di Benedetto A; Scilipoti A; Santamaria A; Interdonato ML; Petrella E; Neri I; Pintaudi B; Corrado F; Facchinetti F
    Obstet Gynecol; 2015 Aug; 126(2):310-315. PubMed ID: 26241420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Wei J; Yan J; Yang H
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review.
    D'Anna R; Santamaria A; Alibrandi A; Corrado F; DI Benedetto A; Facchinetti F
    J Nutr Sci Vitaminol (Tokyo); 2019; 65(Supplement):S59-S61. PubMed ID: 31619648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy.
    Cavalli P; Tonni G; Grosso E; Poggiani C
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):962-5. PubMed ID: 21956977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials.
    Vitagliano A; Saccone G; Cosmi E; Visentin S; Dessole F; Ambrosini G; Berghella V
    Arch Gynecol Obstet; 2019 Jan; 299(1):55-68. PubMed ID: 30564926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects.
    Cogram P; Tesh S; Tesh J; Wade A; Allan G; Greene ND; Copp AJ
    Hum Reprod; 2002 Sep; 17(9):2451-8. PubMed ID: 12202440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study.
    D'Anna R; Scilipoti A; Giordano D; Caruso C; Cannata ML; Interdonato ML; Corrado F; Di Benedetto A
    Diabetes Care; 2013 Apr; 36(4):854-7. PubMed ID: 23340885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial.
    Santamaria A; Di Benedetto A; Petrella E; Pintaudi B; Corrado F; D'Anna R; Neri I; Facchinetti F
    J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3234-7. PubMed ID: 26698911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of gestational diabetes recurrence and the development of type 2 diabetes among women with a history of gestational diabetes and risk factors: a study among 18 clinical centers in China.
    Wei Y; Juan J; Su R; Song G; Chen X; Shan R; Li Y; Cui S; Fan S; Feng L; You Z; Meng H; Cai Y; Zhang C; Yang H
    Chin Med J (Engl); 2022 Mar; 135(6):665-671. PubMed ID: 35348312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies.
    Wilson RD; ; Wilson RD; Audibert F; Brock JA; Carroll J; Cartier L; Gagnon A; Johnson JA; Langlois S; Murphy-Kaulbeck L; Okun N; Pastuck M; ; Deb-Rinker P; Dodds L; Leon JA; Lowel HL; Luo W; MacFarlane A; McMillan R; Moore A; Mundle W; O'Connor D; Ray J; Van den Hof M
    J Obstet Gynaecol Can; 2015 Jun; 37(6):534-52. PubMed ID: 26334606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HbA1c: A Useful Screening Test for Gestational Diabetes Mellitus.
    Soumya S; Rohilla M; Chopra S; Dutta S; Bhansali A; Parthan G; Dutta P
    Diabetes Technol Ther; 2015 Dec; 17(12):899-904. PubMed ID: 26496534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.